Table 2.

AAIT improved clinical events and symptoms in the treated 12 patients

Patient	Symptoms before AAIT		Clinical response after AAIT treatment
	AIDS-related events at enrollment	Systemic constitutional symptoms at enrollment
01-W	Pneumonia Sepsis Crysptosporidiosis EBV infection Wasting syndrome	+++	No new opportunistic infections, doing well
02-Z	Pneumonia Pulmonary abscess Colitis EBV infection Wasting syndrome	+++++	Pulmonary abscess significantly improved within 1 month, doing well
03-G	Pneumonia PCP	++	No new opportunistic infections, doing well
04-D	Pneumonia CMV infection Wasting syndrome	++++	No new opportunistic infections, doing well
05-Z	Pneumonia PCP Oral candidiasis	++	No new opportunistic infections, doing well
06-L	Pneumonia PCP CMV infection EBV infection	++	No new opportunistic infections, doing well
07-X	Pneumonia PCP Oral candidiasis	+++	Phlegmon occurs 37 days later
08-D	Pneumonia PCP Oral candidiasis Wasting syndrome	+++	No new opportunistic infections, doing well
09-L	Cryptosporidium enteritis Salmonella typhimurium enteritis Oral candidiasis CMV infection Wasting syndrome	++++	No new opportunistic infections, doing well
10-L	Pneumonia PCP	++	No new opportunistic infections, doing well
11-S	Pneumonia PCP Oral candidiasis	++	No new opportunistic infections, doing well
12-L	Pneumonia PCP Oral candidiasis CMV infection	++	No new opportunistic infections, doing well

Clinical events and symptoms of 12 severely immunosuppressed AIDS patients were carefully recorded within 1 year after AAIT treatment. Systemic constitutional symptoms included intermittent or continuous fever (38 °C) for more than 1 month repeated night sweats, debilitating fatigue, persistent diarrhea, and a loss of body weight of more than 10%, each “+” represents a symptom

PCP pneumocystis carinii pneumonia, EBV Epstein–Barr virus, CMV cytomegalovirus